FDC Financial Statement Analysis
|
||
|
The Revenues of FDC have increased by 16.74% YoY .
The Earnings Per Share (EPS) of FDC has decreased by -8.74 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
FDC Last 5 Annual Financial Results
[BOM: 531599|NSE : FDC]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr | ₹1,344 Cr | ₹1,091 Cr |
| Expenses | ₹1,534 Cr | ₹1,274 Cr | ₹999 Cr | ₹1,051 Cr | ₹860 Cr |
| Operating Profit (Excl OI) | ₹250 Cr | ₹254 Cr | ₹334 Cr | ₹293 Cr | ₹231 Cr |
| Other Income | ₹51 Cr | ₹76 Cr | ₹97 Cr | ₹69 Cr | ₹43 Cr |
| Interest | ₹4.09 Cr | ₹3.09 Cr | ₹3.43 Cr | ₹3.42 Cr | ₹1.44 Cr |
| Depreciation | ₹39 Cr | ₹37 Cr | ₹38 Cr | ₹37 Cr | ₹33 Cr |
| Profit Before Tax | ₹258 Cr | ₹289 Cr | ₹388 Cr | ₹320 Cr | ₹237 Cr |
| Profit After Tax | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr | ₹170 Cr |
| Consolidated Net Profit | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr | ₹170 Cr |
| Earnings Per Share (Rs) | ₹11.70 | ₹12.82 | ₹17.85 | ₹14.03 | ₹9.74 |
| PAT Margin (%) | 10.54 | 13.74 | 22.06 | 17.40 | 15.15 |
| ROE(%) | 9.84 | 11.71 | 18.36 | 16.03 | 12.48 |
| ROCE(%) | 13.25 | 15.78 | 23.74 | 21.56 | 17.49 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 7,370.8 Cr |
| Revenue (TTM) | : | ₹ 1,915.7 Cr |
| Net Profit(TTM) | : | ₹ 289.4 Cr |
| EPS (TTM) | : | ₹ 17.8 |
| P/E (TTM) | : | 25.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FDC | -1.3% | -11% | 71.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
FDC Revenues
[BOM: 531599|NSE : FDC]
| Y-o-Y | 16.74 % |
| 5 Yr CAGR | 13.09 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | 14.61 | |
| Mar2021 | ₹1,333 Cr | -0.82 | |
| Mar2020 | ₹1,344 Cr | 23.24 | |
| Mar2019 | ₹1,091 Cr | - | |
FDC Operating Profit
[BOM: 531599|NSE : FDC]
| Y-o-Y | -1.61 % |
| 5 Yr CAGR | 1.95 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹250 Cr | -1.61 | |
| Mar2022 | ₹254 Cr | -24.06 | |
| Mar2021 | ₹334 Cr | 14.03 | |
| Mar2020 | ₹293 Cr | 26.81 | |
| Mar2019 | ₹231 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -15.72 % |
| 5 Yr CAGR | -9.85 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 13.99% | -15.72 | |
| Mar2022 | 16.6% | -33.76 | |
| Mar2021 | 25.06% | 15.01 | |
| Mar2020 | 21.79% | 2.88 | |
| Mar2019 | 21.18% | - | |
FDC Profit After Tax
[BOM: 531599|NSE : FDC]
| Y-o-Y | -10.34 % |
| 5 Yr CAGR | 3.39 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹194 Cr | -10.34 | |
| Mar2022 | ₹216 Cr | -28.19 | |
| Mar2021 | ₹301 Cr | 25.62 | |
| Mar2020 | ₹240 Cr | 41.28 | |
| Mar2019 | ₹170 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -23.29 % |
| 5 Yr CAGR | -8.67 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 10.54 % | -23.29 | |
| Mar2022 | 13.74 % | -37.72 | |
| Mar2021 | 22.06 % | 26.78 | |
| Mar2020 | 17.4 % | 14.85 | |
| Mar2019 | 15.15 % | - | |
FDC Earnings Per Share (EPS)
[BOM: 531599|NSE : FDC]
| Y-o-Y | -8.74 % |
| 5 Yr CAGR | 4.69 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹12 | -8.74 | |
| Mar2022 | ₹13 | -28.18 | |
| Mar2021 | ₹18 | 27.23 | |
| Mar2020 | ₹14 | 44.05 | |
| Mar2019 | ₹9.74 | - | |
FDC Return on Capital Employed (ROCE)
[BOM: 531599|NSE : FDC]
| Y-o-Y | -16.03 % |
| 5 Yr CAGR | -6.71 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 13.25% | -16.03 | |
| Mar2022 | 15.78% | -33.53 | |
| Mar2021 | 23.74% | 10.11 | |
| Mar2020 | 21.56% | 23.27 | |
| Mar2019 | 17.49% | - | |
FDC Share Price vs Sensex
| Current Share Price | : | ₹452.8 |
| Current MarketCap | : | ₹ 7,370.8 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1.3% |
-11% |
71.9% |
| SENSEX | 1.3% |
2.6% |
24% |
FDC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE 250 SMALLCAP | 2.5% | 12.8% | 64.9% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
| S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 2.8% | 13.8% | 71.1% |
| NIFTY MID SMALL400 | 2.1% | 10.7% | 62.3% |
| NIFTY500 MULTICAP 50:25:25 | 1.8% | 7.7% | 48.1% |
| NIFTY 500 | 1.5% | 5.7% | 39.5% |
You may also like the below Video Courses
FAQ about FDC Financials
How the annual revenues of FDC have changed ?
The Revenues of FDC have increased by 16.74% YoY .
How the Earnings per Share (EPS) of FDC have changed?
The Earnings Per Share (EPS) of FDC has decreased by -8.74 % YoY .
Check out Intrinsic Value of Peers of FDC
Compare Stock Analytics of Peers of FDC
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
